Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» Servier
Servier
Servier acquires lymphoma drug Pixuvri from CTI BioPharma
Pharmaceutical Business Review
Tue, 10/1/19 - 10:50 pm
Pixuvri
Servier
CTI BioPharma
M&A
lymphoma
Servier begins manslaughter trial over weight loss drug
Endpoints
Mon, 09/23/19 - 07:32 pm
Servier
patient deaths
weight loss
Mediator
Companies file suit in Canada challenging new rules to lower drug prices
Yahoo/Reuters
Sun, 08/25/19 - 05:10 pm
drug pricing
Canada
Janssen
Merck
Bayer
Servier
Boehringer Ingelheim
Ipsen, Servier announce initial phase 1/2 data of liposomal irinotecan in metastatic pancreatic cancer
Pharmaceutical Business Review
Mon, 07/8/19 - 10:25 am
Ipsen
Servier
liposomal irinotecan
pancreatic cancer
Servier, armed with Shire cancer drugs, builds out vision for U.S. future
Fierce Pharma
Fri, 06/7/19 - 12:47 pm
Servier
oncology
Shire
M&A
Amgen, Servier heart failure drug clears trial hurdle
PM Live
Thu, 03/21/19 - 06:50 pm
Amgen
Servier
heart failure
Omecamtiv Mecarbil
clinical trials
Servier and Oncodesign announce Parkinson’s R&D tie-up
Pharmaforum
Wed, 03/13/19 - 11:18 pm
Servier
Oncodesign
R&D
Parkinson's Disease
Amgen and partners begin second phase 3 trial of omecamtiv mecarbil in patients with heart failure
Pharmaceutical Business Review
Fri, 02/22/19 - 10:04 am
Amgen
heart failure with reduced ejection fraction
Omecamtiv Mecarbil
Cytokinetics
Servier
FDA approves Servier's ALL therapy, acquired in Shire deal
BioCentury
Fri, 12/21/18 - 04:09 pm
FDA
SHP663
Servier
ALL
Servier drops GeNeuro’s multiple sclerosis drug after midphase miss
Fierce Biotech
Tue, 09/18/18 - 09:48 am
Servier
GeNeuro
MS
multiple sclerosis
GNbAC1
Phase III Trial Data Demonstrates Significant Overall Survival Benefit of Lonsurf (trifluridine and tipiracil) in Patients with Metastatic Gastric Cancer
CP Wire
Thu, 06/21/18 - 10:13 am
Servier
Taiho Pharmaceutical
Lonsurf
gastric cancer
Phase III Trial Data Demonstrates Significant Overall Survival Benefit of Lonsurf (trifluridine and tipiracil) in Patients with Metastatic Gastric Cancer
Thu, 06/21/18 - 09:53 am
Servier
Taiho Pharmaceutical
Lonsurf
gastric cancer
Servier opens Kendall Square site, plans Chinese office to access external innovation
Fierce Biotech
Thu, 06/7/18 - 11:00 pm
Servier
Kendall Square
Boston
Biogen
R&D
Shire's oncology exit weighs on potential Takeda bid
Biopharma Dive
Tue, 04/17/18 - 09:37 am
Shire
oncology
Takeda
M&A
Servier
Servier buys Shire’s oncology unit for $2.4B in the run-up to Takeda’s final buyout offer — if it makes one
Endpoints
Mon, 04/16/18 - 09:12 am
Servier
Shire
Takeda
M&A
oncology
Servier, Pfizer get FDA OK to start US testing of an off-the-shelf CAR-T from Cellectis
Endpoints
Thu, 03/9/17 - 11:34 am
Pfizer
Servier
FDA
CAR-T
UCART19
Cellectis
acute lymphocytic leukemia
Servier Joins Hands With Intarcia Therapeutics To Develop Implantable Diabetic Pump
Bidness Etc.
Thu, 11/13/14 - 12:56 pm
Servier
Intarcia
diabetes
devices
Pharmacyclics, Servier call it quits on a cancer drug
Fierce Biotech
Fri, 09/26/14 - 09:05 am
Pharmacyclics
Servier
Abexinostat
SIGNIFY Trial Provokes Sound And Fury Over Controversial Servier and Amgen Drug
Forbes
Mon, 09/1/14 - 09:50 am
clinical trials
Amgen
SIGNIFY
Servier
Procoralan
Corlentor
Servier to Teva Fined $582.2 Million on Generic Delays
Bloomberg
Wed, 07/9/14 - 07:47 am
Servier
Teva Pharmaceutical
generics
perindopril
Pages
« first
‹ previous
1
2
3
next ›
last »